1. Home
  2. RELI vs TCRT Comparison

RELI vs TCRT Comparison

Compare RELI & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RELI
  • TCRT
  • Stock Information
  • Founded
  • RELI 2013
  • TCRT 1998
  • Country
  • RELI United States
  • TCRT United States
  • Employees
  • RELI N/A
  • TCRT N/A
  • Industry
  • RELI Specialty Insurers
  • TCRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RELI Finance
  • TCRT Health Care
  • Exchange
  • RELI Nasdaq
  • TCRT Nasdaq
  • Market Cap
  • RELI 3.5M
  • TCRT 3.8M
  • IPO Year
  • RELI N/A
  • TCRT N/A
  • Fundamental
  • Price
  • RELI $1.27
  • TCRT $3.00
  • Analyst Decision
  • RELI
  • TCRT
  • Analyst Count
  • RELI 0
  • TCRT 0
  • Target Price
  • RELI N/A
  • TCRT N/A
  • AVG Volume (30 Days)
  • RELI 228.6K
  • TCRT 58.3K
  • Earning Date
  • RELI 07-30-2025
  • TCRT 08-13-2025
  • Dividend Yield
  • RELI N/A
  • TCRT N/A
  • EPS Growth
  • RELI N/A
  • TCRT N/A
  • EPS
  • RELI N/A
  • TCRT N/A
  • Revenue
  • RELI $14,208,143.00
  • TCRT $11,000.00
  • Revenue This Year
  • RELI N/A
  • TCRT $5,680,500.00
  • Revenue Next Year
  • RELI N/A
  • TCRT N/A
  • P/E Ratio
  • RELI N/A
  • TCRT N/A
  • Revenue Growth
  • RELI 2.40
  • TCRT 83.33
  • 52 Week Low
  • RELI $0.97
  • TCRT $1.31
  • 52 Week High
  • RELI $5.11
  • TCRT $6.20
  • Technical
  • Relative Strength Index (RSI)
  • RELI 40.11
  • TCRT 37.01
  • Support Level
  • RELI $1.41
  • TCRT $2.50
  • Resistance Level
  • RELI $1.54
  • TCRT $3.22
  • Average True Range (ATR)
  • RELI 0.11
  • TCRT 0.49
  • MACD
  • RELI -0.04
  • TCRT -0.18
  • Stochastic Oscillator
  • RELI 7.84
  • TCRT 13.51

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

Share on Social Networks: